rs1725797806
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 1P and 0B. PP3
The NM_001319236.2(RPL34):c.16A>C(p.Thr6Pro) variant causes a missense change involving the alteration of a conserved nucleotide. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001319236.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 38AN: 151826Hom.: 0 Cov.: 33 FAILED QC
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0172 AC: 23812AN: 1387564Hom.: 0 Cov.: 29 AF XY: 0.0161 AC XY: 11164AN XY: 692486
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.000244 AC: 37AN: 151944Hom.: 0 Cov.: 33 AF XY: 0.000242 AC XY: 18AN XY: 74264
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.16A>C (p.T6P) alteration is located in exon 2 (coding exon 1) of the RPL34 gene. This alteration results from a A to C substitution at nucleotide position 16, causing the threonine (T) at amino acid position 6 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at